Our findings demonstrated that the G3BP1 K76R mutant significantly enhanced both cisplatin resistance and the migratory and invasive abilities of NPC cells (Figure S7B,C, Supporting Information). This evidence concerns the gene G3BP1 and nasopharyngeal carcinoma.